- Home
- CENX vs BCRX Comparison
CENX vs BCRX Comparison
Compare CENX & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CENX
- BCRX
- Stock Information
- Founded
- CENX 1995
- BCRX 1986
- Country
- CENX United States
- BCRX United States
- Employees
- CENX N/A
- BCRX N/A
- Industry
- CENX Aluminum
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CENX Industrials
- BCRX Health Care
- Exchange
- CENX Nasdaq
- BCRX Nasdaq
- Market Cap
- CENX 2.0B
- BCRX 1.8B
- IPO Year
- CENX 1996
- BCRX 1994
- Fundamental
- Price
- CENX $26.05
- BCRX $7.75
- Analyst Decision
- CENX Strong Buy
- BCRX Strong Buy
- Analyst Count
- CENX 3
- BCRX 10
- Target Price
- CENX $25.00
- BCRX $16.70
- AVG Volume (30 Days)
- CENX 1.5M
- BCRX 2.3M
- Earning Date
- CENX 11-03-2025
- BCRX 11-03-2025
- Dividend Yield
- CENX N/A
- BCRX N/A
- EPS Growth
- CENX N/A
- BCRX N/A
- EPS
- CENX 1.20
- BCRX N/A
- Revenue
- CENX $2,432,000,000.00
- BCRX $557,506,000.00
- Revenue This Year
- CENX $14.62
- BCRX $41.34
- Revenue Next Year
- CENX $0.83
- BCRX $6.11
- P/E Ratio
- CENX $21.82
- BCRX N/A
- Revenue Growth
- CENX 15.38
- BCRX 45.85
- 52 Week Low
- CENX $13.05
- BCRX $6.02
- 52 Week High
- CENX $26.85
- BCRX $11.31
- Technical
- Relative Strength Index (RSI)
- CENX 54.58
- BCRX 50.07
- Support Level
- CENX N/A
- BCRX N/A
- Resistance Level
- CENX $26.10
- BCRX $8.13
- Average True Range (ATR)
- CENX 0.92
- BCRX 0.19
- MACD
- CENX -0.54
- BCRX -0.33
- Stochastic Oscillator
- CENX 98.15
- BCRX 89.29
About CENX Century Aluminum Company
Century Aluminum Co produces primary aluminum standard grade and value-added products. The firm operates smelter facilities in the United States and Iceland. The majority of revenue is generated from Glencore, which agreed to purchase nearly all of Century Aluminum's North American production. Century purchases nearly all of its alumina from Glencore. The company produces high purity aluminum, standard-grade aluminum sow and tee bars, and value-added billet and foundry products. Century also owns a carbon anode production facility in the Netherlands.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.